期刊文献+

狼疮肾炎患者血清及外周血单个核细胞中IL-10和γ干扰素的表达及意义 被引量:12

Study on levels in serum and mRNA expression in PBMCs of interleukin-10 and interferon-γ of patients with lupus nephritis
下载PDF
导出
摘要 目的探讨Th1型和Th2型细胞因子在LN发病机制中的作用。方法活动期和非活动期LN患者各30例、健康对照者30例,分别采取外周静脉血,应用逆转录-荧光定量-聚合酶链反应(RT-FQ-PCR)技术及ELISA方法定量分析LN患者外周血单个核细胞(PBMC)中白介素-10(IL-10)和γ干扰素(IFN-γ)mRNA及血清中IL-10、IFN-γ的自然表达水平。结果活动期和非活动期LN患者血清和PBMC的IL-10水平均显著高于正常对照组,而活动期与非活动期LN患者的IL-10水平比较,差异无显著性。活动期LN患者IFN-γ水平显著高于正常对照组,而非活动期LN患者IFN-γ水平虽有增加趋势,但与正常对照组相比差异无显著性。活动期和非活动期LN患者血清和PBMC的IL-10/IFN-γ的比值与正常对照组比较,差异无显著性。结论LN患者血清和PBMC的IL-10自然表达水平明显增高,但其增高程度与疾病活动度无明显相关;活动期LN患者IFN-γ的表达也显著增高,提示Th1和Th2型细胞因子均可能参与活动期LN的炎症反应及组织损伤。 [Objective ] To investigate the levels in the serum and mRNA expression in PBMCs of interleukin-10 and interferon-γ of patients with lupus nephritis (LN) and try to understand the role Of Th1/Th2 cytokines in the pathogenesis of LN. [Methods] 60 LN patients and 30 healthy controls were selected. RT-FQ-PCR was used to detect the mRNA expression of interleukin 10 (IL-10) and interferon-γ(IFN-γ) in PBMCs and levels Of serum were measured by ELISA. [Results] The mRNA expressions and levels of serum of IL-10 were both higher than those from the controls. And there was no significant difference between active LN and inactive LN. The mRNA expressions and levels of serum IFN-γ in active LN patients were increased compared with control group. But no difference was found between inactive LN and normal controls, while there was trend of increase in inactive LN. The ratio of IL-10/IFN-γ was not different between LN patients and normal controls. [Conclusions] Either the IL-10 levels in serum or IL-10 mRNA expression were significantly increased in LN patients, but it did not reflect the disease activities in LN. And IFN-γ levels in serum and IFN-γ mRNA expression were increased in active LN patients. Abnormally high expression of Th1 and Th2 eytokines might contribute to the inflammatory damages of LN.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第4期529-532,共4页 China Journal of Modern Medicine
  • 相关文献

参考文献12

  • 1叶任高.系统性红斑狼疮内科学[M].第5版.北京:人民卫生出版社,2000:909-915.
  • 2BOMBARDIER C,GLADMAN DD,UROWITZ MB,et al.Derivation of the SLEDAI:A disease activity index for lupus patients.The committee on prognosis studies in SLE[J].Arthritis Rheum,1992,35(6):630-640.
  • 3孙雪峰,苏金环,叶任高.中西医结合治疗狼疮性肾炎的荟萃分析(英文)[J].中国现代医学杂志,2004,14(17):23-28. 被引量:5
  • 4MOSMANN TR,SAD S.The expanding universe of T-cell subsets:Th1,Th2 and more[J].Immunol Today,1996,17(3):138-146.
  • 5LIORENTE L,ZOU W,LEVY Y,et al.Role of interleukin 10in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus[J].J Exp Med,1995,181(3):839-844.
  • 6TAGA K,MOSTOWSKI H,TOSATO G.Human interleukin 10can directly inhibit T cell growth[J].Blood,1993,81 (11):2964-2971.
  • 7ISHIDA H,MUCHAMUEL T,SAKAGUCHI S,et al.Continuous administration of anti-interleukin10 antibodies delays the onset of autoimmunity in NZB/W F1 mice[J].J Exp Med,1994,179(1):305-310.
  • 8LIORENTE L,RICHAUD-PATIN Y,COUDERC J,et al.Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus[J].Arthritis Rheum,1997,40(8):1429-1435.
  • 9ESKDALE J,WORDSWORTH P,BOWMAN S,et al.Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus[J].Tissue Antigens,1997,49(6):635-639.
  • 10BALOMENOS D,RUMOLD B,THEOFILOPOULOS AN.Interferon-γ in required for lupus-like disease and lymphoaccumulation in MRL/lpr mice[J].J Clin Invest,1998,101(2):364-371.

二级参考文献28

  • 1WEN BM. Control study of lupus nephritis treated with integrated traditional and western medicine[J]. Shanxi Zhongyi xueyuan Xuebao, 1998, 21:19-20. Chinese
  • 2SHI MY, HU QY, SUN LH, et al. observation on therapeutic effect in 63 patients with systemic lupus erythematosus treated with integrated traditional and western medicine [J]. Zhongguo Pifu Xingbingxue Zazhi, 1998, 12: 159-160. Chinese
  • 3LIU EQ. Observtion on therapeutic effect in 26 patients with lupus nephritis treated with integrated traditional Chinese medicine with western medicine. Zhongguo Yikan, 1999, 34:51-52. Chinese
  • 4YIN JF, LU JJ, YE RG. Observation on therapeutic effect in 198 patients with lupus nephritis treated with integrated Chinese medicine with western medicine. Jiangxi Yi Yao, 1999,34:51-52. Chinese
  • 5ZHANG WX, GONG ZF. Observation on therapeutic effect in 40 patients with lupus nephritis treated with integrated traditional Chinese medicine with western medicine. Guangxi Zhong Yi Yao, 1999, 22: 11-14. Chinese
  • 6HU RF. Observation on therapeutic effect in 30 patients with lupus nephritis treated with integrated traditional and western medicine[J]. Zhongguo Xiandai Yixue Zazhi, 1999, 9: 68-69.Chinese.
  • 7ZHONG YX. Clinical observation on therapeutic effect in 58 patients with lupus nephritis treated with integrated traditional and western medicine[J]. Zhongguo Yishi Zazhi, 2000, 2: 187-188. Chinese
  • 8YANG X, YE RG, PAI CC, et al. Clinical observation on therapeutic effect in 32 patients with lupus nephritis treated with combination of lupus recipe and immunosuppressor [J].Zhongguo Yi Kan, 2000, 35: 45-46. Chinese
  • 9ZHANG LJ, WANG AL. Clinical observation on therapeutic effect in 32 patients with lupus nephritis treated with integrated traditional and western medicine[J]. Zhejiang Zhongyi Xueyuan Xuebao, 2000, 24: 40. Chinese
  • 10LU XD, ZHANG XK. Experiences on treatment with integrated traditional and western medicine in lupus nephritis[J]. Xiandai Zhongxiyi Jiehe Zazhi, 2000, 9: 324-325. Chinese

共引文献4

同被引文献80

引证文献12

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部